Assessment of complement-binding anti-HLA antibodies predicts kidney-allograft loss risk, suggesting potential for improved patient management.
Assessment of the complement-binding capacity of donor-specific anti-HLA antibodies appears to be useful in identifying patients at high risk for kidney-allograft loss.
No takes yet. Share an insight, caveat, or question.
Loupy et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: